Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
FibroBiologics, Inc. ( (FBLG) ) has issued an update.
On May 4, 2026, FibroBiologics, Inc.’s compensation committee granted stock options under its 2022 Stock Plan to senior executives, including options to purchase 92,410 shares to Chief Executive Officer Pete O’Heeron and 61,607 shares each to Chief Financial Officer Jason D. Davis, Chief Scientific Officer Hamid Khoja, Ph.D., and General Counsel Ruben A. Garcia. The options, with an exercise price of $1.38 per share, vest over four years, with 25% vesting after one year and the remainder in 36 equal monthly installments, aligning executive incentives with long-term company performance and shareholder interests.
The grants reflect FibroBiologics’ use of equity-based compensation to retain key leadership and support continuity in executing its scientific and commercial strategy.
The most recent analyst rating on (FBLG) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on FibroBiologics, Inc. stock, see the FBLG Stock Forecast page.
Spark’s Take on FBLG Stock
According to Spark, TipRanks’ AI Analyst, FBLG is a Neutral.
The score is held down primarily by weak financial performance (no revenue, widening losses, heavy cash burn) and a strongly bearish technical setup (deeply below key moving averages with negative MACD). Corporate events provide some offset via regained Nasdaq compliance and cost-saving actions, but monitoring/delisting risk and capital structure actions remain notable. Valuation is constrained by a negative P/E and no dividend support.
To see Spark’s full report on FBLG stock, click here.
More about FibroBiologics, Inc.
FibroBiologics, Inc. is a biotechnology company focused on developing therapies based on fibroblast cell biology, with a management team that includes a chief executive officer, chief financial officer, chief scientific officer, and general counsel guiding its strategic, financial, and research operations.
Average Trading Volume: 381,446
Technical Sentiment Signal: Sell
Current Market Cap: $7.19M
See more data about FBLG stock on TipRanks’ Stock Analysis page.